All In Biotech

Drug Trial Radar · NCT06568042

Effects of LY3848575 Versus Placebo in Participants With Painful Distal Sensory Polyneuropathy

A Phase 2, Randomized, Double-Blind, Placebo Controlled, Dose-Finding Study Evaluating LY3848575 in Chronic Neuropathic Pain Associated With Distal Sensory Polyneuropathy

Last checked: Nov 19, 2026Latest source record: Jul 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 558 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

558

Actual

Start

Aug 22, 2024

Primary completion

Jan 12, 2026

Study completion Apr 15, 2026

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
Aug 23, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate how safe and how well a treatment works compared to placebo for people with nerve pain that begins in their feet and moves up the leg to just below the knee. Participation may last up to 30 weeks including screening.

Conditions

  • Neuropathic Pain
  • Distal Sensory Polyneuropathy

Interventions

  • LY3848575Drug

    Administered SC

  • PlaceboDrug

    Administered SC

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean Change from Baseline in Average Pain Intensity Numeric Rating Scale (API-NRS)Time frame: Baseline, Week 12

Locations

76 sites in 7 countries. Site status is shown where the registry gives one.

  • MD First Research - Chandler

    Chandler, Arizona

  • HOPE Research Institute

    Phoenix, Arizona

  • Neuro-Pain Medical Center

    Fresno, California

  • Alpine Clinical Research Center

    Boulder, Colorado

  • Accel Research Sites - St. Pete-Largo Clinical Research Unit

    Largo, Florida

  • Design Neuroscience Center

    Miami Lakes, Florida

  • Conquest Research - Orlando

    Orlando, Florida

  • Charter Research - Lady Lake

    The Villages, Florida

  • Encore Medical Research - Weston

    Weston, Florida

  • Conquest Research

    Winter Park, Florida

  • Integrated Clinical Trial Services, Inc.

    West Des Moines, Iowa

  • Lucida Clinical Trials

    New Bedford, Massachusetts

  • SKY Integrative Medical Center/SKYCRNG

    Ridgeland, Mississippi

  • StudyMetrix Research

    City of Saint Peters, Missouri

  • Mid Hudson Medical Research

    New Windsor, New York

  • University of Rochester Medical Center

    Rochester, New York

  • Asheville Neurology Specialists, PA

    Asheville, North Carolina

  • Center for Clinical Research

    Winston-Salem, North Carolina

  • Neurology Diagnostics, Inc.

    Dayton, Ohio

  • New Phase Research and Development

    Knoxville, Tennessee

  • Cedar Health Research

    Dallas, Texas

  • Biopharma Informatic, LLC

    Houston, Texas

  • Clinical Trial Network

    Houston, Texas

  • Northwest Clinical Research Center

    Bellevue, Washington

  • Med Trust Research

    Courtice, Canada

  • Dawson Clinical Research Inc.

    Guelph, Canada

  • Premier Clinical Trial Network

    Hamilton, Canada

  • OCT Research ULC

    Kelowna, Canada

  • Genge Partners

    Montreal, Canada

  • Richmond Clinical Trials

    Richmond, Canada

  • Bluewater Clinical Research Group Inc.

    Sarnia, Canada

  • FutureMeds GmbH

    Berlin, Germany

  • Studienzentrum Dr. Bischof GmbH

    Böblingen, Germany

  • Universitaetsklinikum Schleswig-Holstein Campus Kiel

    Kiel, Germany

  • ZNS Siegen

    Siegen, Germany

  • Studienzentrum Nord-West

    Westerstede, Germany

  • St. Luke's International Hospital

    Chūōku, Japan

  • Chugoku Central Hospital

    Fukuyama-shi, Japan

  • Mito Medical Center

    Higashiibaraki, Japan

  • Rinku General Medical Center

    Izumisano, Japan

Showing 40 of 76 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.